Sign in

CIK 0001446847

  • Accelerated filer
  • Smaller reporting company

IRONWOOD PHARMACEUTICALS INC

Sign in to watch
Ticker
IRWD
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
043404176
Phone
+1 617-621-7722
Business address
100 SUMMER STREET, SUITE 2300, BOSTON, MA, 02110
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$28,470
in 1 filing

Net −$28,470. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Gaskins Tammi L −$28K Chief Commercial Officer sold 2% of stake

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2025-06-10 Dreyfus Andrew Director Grant or award +45,000 228,313
2024-06-18 Dreyfus Andrew Director Grant or award +24,311 188,230
2023-06-20 Dreyfus Andrew Director Grant or award +22,350 168,980
2022-06-01 Dreyfus Andrew Director Grant or award +21,571 151,639
2021-12-15 Dreyfus Andrew Director Grant or award +1,431 130,077
2021-09-15 Dreyfus Andrew Director Grant or award +1,344 134,660
2021-06-15 Dreyfus Andrew Director Grant or award +1,453 133,316
2021-06-02 Dreyfus Andrew Director Grant or award +22,766 131,863
2021-03-15 Dreyfus Andrew Director Grant or award +1,460 109,097
2020-12-15 Dreyfus Andrew Director Grant or award +1,357 113,360
2020-09-15 Dreyfus Andrew Director Grant or award +1,600 112,003
2020-06-15 Dreyfus Andrew Director Grant or award +1,745 110,403
2020-06-03 Dreyfus Andrew Director Grant or award +21,720 108,658
2020-03-13 Dreyfus Andrew Director Grant or award +1,596 86,938

Page 1 of 1 · 14 trades